Elena Crestani

Publications

1. RELMß sets the threshold for microbiome-dependent oral tolerance. Nature. 2025 Jan 22. View Abstract
2. Notch4 regulatory T cells and SARS-CoV-2 viremia shape COVID19 survival outcome. Allergy. 2024 Oct 03. View Abstract
3. An Atypical Case of Parotid Swelling. Pediatr Rev. 2024 Sep 01; 45(9):535-539. View Abstract
4. Age-specific Metabolomic profiles in children with food allergy. Clin Immunol. 2024 04; 261:109928. View Abstract
5. Piloting a multidisciplinary group education session to support caregivers of children with food protein-induced enterocolitis syndrome (FPIES). J Allergy Clin Immunol Pract. 2023 Oct; 11(10):3260-3262.e1. View Abstract
6. The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2-associated multisystem inflammatory syndrome in children. J Clin Invest. 2023 01 03; 133(1). View Abstract
7. SARS-CoV-2-specific T cell responses in patients with multisystem inflammatory syndrome in children. Clin Immunol. 2022 Oct; 243:109106. View Abstract
8. A common IL-4 receptor variant promotes asthma severity via a Treg cell GRB2-IL-6-Notch4 circuit. Allergy. 2022 11; 77(11):3377-3387. View Abstract
9. Atopic Dermatitis Mediates the Association Between an IL4RA Variant and Food Allergy in School-Aged Children. J Allergy Clin Immunol Pract. 2022 08; 10(8):2117-2124.e4. View Abstract
10. Notch1-CD22-Dependent Immune Dysregulation in the SARS-CoV2-Associated Multisystem Inflammatory Syndrome in Children. Res Sq. 2022 Apr 11. View Abstract
11. A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune-epithelial interface. Proc Natl Acad Sci U S A. 2022 01 04; 119(1). View Abstract
12. Author Correction: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat Immunol. 2021 Jun; 22(6):794-795. View Abstract
13. Notch4 signaling limits regulatory T-cell-mediated tissue repair and promotes severe lung inflammation in viral infections. Immunity. 2021 06 08; 54(6):1186-1199.e7. View Abstract
14. Author Correction: A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat Immunol. 2021 Jan; 22(1):100. View Abstract
15. Regulatory T Cell-Derived TGF-ß1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity. Immunity. 2020 Dec 15; 53(6):1331-1332. View Abstract
16. Regulatory T Cell-Derived TGF-ß1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity. Immunity. 2020 12 15; 53(6):1202-1214.e6. View Abstract
17. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. J Allergy Clin Immunol Pract. 2020 10; 8(9S):S16-S116. View Abstract
18. A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. Nat Immunol. 2020 11; 21(11):1359-1370. View Abstract
19. Dietary and Microbial Determinants in Food Allergy. Immunity. 2020 08 18; 53(2):277-289. View Abstract
20. Untargeted metabolomic profiling identifies disease-specific signatures in food allergy and asthma. J Allergy Clin Immunol. 2020 03; 145(3):897-906. View Abstract
21. Author Correction: Microbiota therapy acts via a regulatory T cell MyD88/ROR?t pathway to suppress food allergy. Nat Med. 2019 Sep; 25(9):1458. View Abstract
22. Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis. Am J Hum Genet. 2019 09 05; 105(3):549-561. View Abstract
23. Microbiota therapy acts via a regulatory T cell MyD88/ROR?t pathway to suppress food allergy. Nat Med. 2019 07; 25(7):1164-1174. View Abstract
24. Systemic Reactions in Pediatric Patients Receiving Standardized Allergen Subcutaneous Immunotherapy with and without Seasonal Dose Adjustment. J Allergy Clin Immunol Pract. 2018 Sep - Oct; 6(5):1711-1716.e4. View Abstract
25. Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial. J Allergy Clin Immunol Pract. 2018 Mar - Apr; 6(2):476-485.e3. View Abstract
26. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016 10 17; 213(11):2413-2435. View Abstract
27. Autoimmune lymphoproliferative syndrome caused by a homozygous FasL mutation that disrupts FasL assembly. J Allergy Clin Immunol. 2016 Jan; 137(1):324-327.e2. View Abstract
28. Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia. J Allergy Clin Immunol. 2015 Nov; 136(5):1401-4.e1-3. View Abstract
29. RAG1 deficiency may present clinically as selective IgA deficiency. J Clin Immunol. 2015 Apr; 35(3):280-8. View Abstract
30. IgE-mediated hypersensitivity reaction and desensitization to glatiramer acetate in a pediatric patient. Pediatr Allergy Immunol. 2014 Dec; 25(8):821-3. View Abstract
31. RAG1 reversion mosaicism in a patient with Omenn syndrome. J Clin Immunol. 2014 Jul; 34(5):551-4. View Abstract
32. Association of IL-5 cytokine production and in vivo IgE levels in infants and parents. J Allergy Clin Immunol. 2007 Oct; 120(4):820-6. View Abstract
33. Exhaled air temperature in asthma: methods and relationship with markers of disease. Clin Exp Allergy. 2007 Mar; 37(3):415-9. View Abstract
34. Parental asthma as a risk factor for the development of early skin test sensitization in children. J Allergy Clin Immunol. 2004 Feb; 113(2):284-90. View Abstract
35. Fractionated total body irradiation in bone marrow transplantation--an emphasis on lung dosimetry. Australas Radiol. 1983 Jul; 27(2):186-94. View Abstract
Show All Publications Show Fewer Publications